U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07309042) titled 'Phase 1 Study of the Safety and Pharmacokinetics of YN001 With Rosuvastatin in Healthy Chinese Subjects' on Nov. 27.
Brief Summary: The primary objective of this study is to investigate the safety and tolerability of YN001 in combination with rosuvastatin, so as to provide evidence for the feasibility of YN001 combined with statins in subsequent clinical trials.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Atherosclerotic Cardiovascular Diseases
Cerebrovascular Diseases
Intervention:
DRUG: YN001, Rosuvastatin calcium Tablets
Cycle 1 (Day 1 to day 14) : YN001, 40 mg, once a week, intravenous infusion, adm...